Allan D. Hess  Biology of Blood and Marrow Transplantation 

Slides:



Advertisements
Similar presentations
Transplantation David Straus, Ph.D. Objectives
Advertisements

Host-Derived CD8+ Dendritic Cells Protect Against Acute Graft-versus-Host Disease after Experimental Allogeneic Bone Marrow Transplantation  Michael Weber,
Comparison of Unmobilized and Mobilized Graft Characteristics and the Implications of Cell Subsets on Autologous and Allogeneic Transplantation Outcomes 
Stephanie J. Lee, Loretta A. Williams 
Frequency of CD4+CD25hiFOXP3+ Regulatory T Cells Has Diagnostic and Prognostic Value as a Biomarker for Acute Graft-versus-Host-Disease  John M. Magenau,
Cytolytic effector mechanisms and gene expression in autologous graft-versus-host disease: distinct roles of perforin and Fas ligand  Yuji Miura, Christopher.
Depletion of Alloreactive Donor T Lymphocytes by CD95-Mediated Activation-Induced Cell Death Retains Antileukemic, Antiviral, and Immunoregulatory T Cell.
Secondary Lymphoid Organs Contribute to, but Are Not Required for the Induction of Graft-versus-Host Responses following Allogeneic Bone Marrow Transplantation:
Influence of Donor Microbiota on the Severity of Experimental Graft-versus-Host- Disease  Isao Tawara, Chen Liu, Hiroya Tamaki, Tomomi Toubai, Yaping Sun,
Juyang Kim, Wongyoung Kim, Hyun J. Kim, Sohye Park, Hyun-A
Th2 Cell Therapy of Established Acute Graft-Versus-Host Disease Requires IL-4 and IL- 10 and Is Abrogated by IL-2 or Host-Type Antigen-Presenting Cells 
Induction of Immunity to Neuroblastoma Early after Syngeneic Hematopoietic Stem Cell Transplantation Using a Novel Mouse Tumor Vaccine  Weiqing Jing,
Ping Zhang, Jieying Wu, Divino Deoliveira, Nelson J. Chao, Benny J
Functional divergence of antigen-specific T-lymphocyte responses in syngeneic graft- versus-host disease  Christopher J Thoburn, Yuji Miura, Emilie C Bright,
Preventive Azithromycin Treatment Reduces Noninfectious Lung Injury and Acute Graft- versus-Host Disease in a Murine Model of Allogeneic Hematopoietic.
Vaccination of Children following Allogeneic Stem Cell Transplantation
Rare cells predict GVHD
Immune Tolerance to Self-Major Histocompatability Complex Class II Antigens after Bone Marrow Transplantation: Role of Regulatory T Cells  Allan D. Hess,
Mark A. Schroeder, Jaebok Choi, Karl Staser, John F. DiPersio 
Assessment of cellular immunity to human cytomegalovirus in recipients of allogeneic stem cell transplants  Simon F Lacey, Don J Diamond, John A Zaia 
Transplantation Rejection of foreign tissue grafts is due to immune responses to alloantigens on the graft Blood group antigens Polymorphic MHC antigens.
Combined CD4+ Donor Lymphocyte Infusion and Low-Dose Recombinant IL-2 Expand FOXP3+ Regulatory T Cells following Allogeneic Hematopoietic Stem Cell Transplantation 
FLT3 ligand administration after hematopoietic cell transplantation increases circulating dendritic cell precursors that can be activated by CpG oligodeoxynucleotides.
CD134-Allodepletion Allows Selective Elimination of Alloreactive Human T Cells without Loss of Virus-Specific and Leukemia-Specific Effectors  Xupeng.
Treatment of Dyslipidemia in Allogeneic Hematopoietic Stem Cell Transplant Patients  Bernard Lawrence Marini, Sung Won Choi, Craig Alan Byersdorfer, Simon.
Identification of a Coordinated CD8 and CD4 T Cell Response Directed Against Mismatched HLA Class I Causing Severe Acute Graft-versus-Host Disease  Avital.
IL-17 Gene Ablation Does Not Impact Treg-Mediated Suppression of Graft-Versus-Host Disease after Bone Marrow Transplantation  Lucrezia Colonna, Mareike.
Evelyn C. Nieves, Tomomi Toubai, Daniel C
The Triterpenoid CDDO-Me Delays Murine Acute Graft-versus-Host Disease with the Preservation of Graft-versus-Tumor Effects after Allogeneic Bone Marrow.
Adoptive Therapy with T Cells/NK Cells
Increase of Intermediate Monocytes in Graft-versus-Host Disease: Correlation with MDR1+Th17.1 Levels and the Effect of Prednisolone and 1α,25-Dihydroxyvitamin.
The Effects of Interleukin 10 and Interferon γ Cytokine Gene Polymorphisms on Survival after Autologous Bone Marrow Transplantation for Patients with.
Inhibition of Cathepsin S Reduces Allogeneic T Cell Priming but Not Graft-versus-Host Disease Against Minor Histocompatibility Antigens  Hisaki Fujii,
Yu-Waye Chu, Ronald E. Gress 
Blocking Activator Protein 1 Activity in Donor Cells Reduces Severity of Acute Graft- Versus-Host Disease through Reciprocal Regulation of IL-17–Producing.
Stephanie J. Lee, Loretta A. Williams 
Quantity and Quality Reconstitution of NKG2A+ Natural Killer Cells Are Associated with Graft-versus-Host Disease after Allogeneic Hematopoietic Cell Transplantation 
Effect of Ex Vivo Culture of CD34+ Bone Marrow Cells on Immune Reconstitution of XSCID Dogs Following Allogeneic Bone Marrow Transplantation  Douglas.
The Triterpenoid CDDO-Me Delays Murine Acute Graft-versus-Host Disease with the Preservation of Graft-versus-Tumor Effects after Allogeneic Bone Marrow.
Single Infusion of Donor Mononuclear Early Apoptotic Cells as Prophylaxis for Graft- versus-Host Disease in Myeloablative HLA-Matched Allogeneic Bone Marrow.
Host Basophils Are Dispensable for Induction of Donor T Helper 2 Cell Differentiation and Severity of Experimental Graft-versus-Host Disease  Isao Tawara,
Th2 Cell Therapy of Established Acute Graft-Versus-Host Disease Requires IL-4 and IL- 10 and Is Abrogated by IL-2 or Host-Type Antigen-Presenting Cells 
Mammalian Target of Rapamycin Inhibitors Permit Regulatory T Cell Reconstitution and Inhibit Experimental Chronic Graft-versus-Host Disease  Haruko Sugiyama,
Visualizing the Immune Synapse
The Expression of Th17-Associated Cytokines in Human Acute Graft-versus-Host Disease  Yuejun Liu, Yifeng Cai, Lan Dai, Guanghua Chen, Xiao Ma, Ying Wang,
Amotosalen-treated donor T cells have polyclonal antigen-specific long-term function without graft-versus-host disease after allogeneic bone marrow transplantation 
Dichotomous Role of Interferon-γ in Allogeneic Bone Marrow Transplant
Tracking ex vivo-expanded CD4+CD25+ and CD8+CD25+ regulatory T cells after infusion to prevent donor lymphocyte infusion-induced lethal acute graft-versus-host.
In Situ Activation and Expansion of Host Tregs: A New Approach to Enhance Donor Chimerism and Stable Engraftment in Major Histocompatibility Complex-Matched.
B Cells and Transplantation: An Educational Resource
B7.2−/− Mature Dendritic Cells Generate T-Helper 2 and Regulatory T Donor Cells in Fetal Mice after In Utero Allogeneic Bone Marrow Transplantation  Swati.
Eva Guinan, Leo Luzmik, Rupert Handgretinger, Ann Woolfrey 
Persistence of host dendritic cells after transplantation is associated with graft-versus- host disease  Geoffrey W. Chan, Gullu Gorgun, Kenneth B. Miller,
Immunology Dr. Refif S. Al-Shawk
CD25 expression distinguishes functionally distinct alloreactive CD4+ CD134+ (OX40+) T-cell subsets in acute graft-versus-host disease  Philip R Streeter,
Content Validity of the Lee Chronic Graft-versus-Host Disease Symptom Scale as Assessed by Cognitive Interviews  Emily C. Merkel, Sandra A. Mitchell,
Heterogeneity in Studies of Mesenchymal Stromal Cells to Treat or Prevent Graft- versus-Host Disease: A Scoping Review of the Evidence  Mina Rizk, Madeline.
Unrelated Stem Cell Transplantation after a Reduced Intensity Conditioning Regimen Containing High-Dose Thymoglobulin Leads to Controllable Graft-versus-Host.
John E. Levine, Sophie Paczesny, Stefanie Sarantopoulos 
Cord Blood Nucleated Cells Induce Delayed T Cell Alloreactivity
Specific donor Vβ-associated CD4+ T-cell responses correlate with severe acute graft- versus-host disease directed to multiple minor histocompatibility.
The Mortimer M. Bortin lecture
Low Serum Levels of Total Rabbit-IgG Is Associated with Acute Graft-Versus-Host Disease after Unrelated Donor Hematopoietic Stem Cell Transplantation:
Gene targeting: Applications in transplantation research
Prospective Monitoring of Tumor Necrosis Factor α and Interferon γ to Predict the Onset of Acute and Chronic Graft-versus-Host Disease after Allogeneic.
Early Recovery of CD4 T Cell Receptor Diversity after “Lymphoablative” Conditioning and Autologous CD34 Cell Transplantation  Jan Storek, Zhao Zhao, Yiping.
Alwi Shatry, Jackeline Chirinos, Michael A
Mary Eapen  Biology of Blood and Marrow Transplantation 
Frequency of CD4+CD25hiFOXP3+ Regulatory T Cells Has Diagnostic and Prognostic Value as a Biomarker for Acute Graft-versus-Host-Disease  John M. Magenau,
Cytotoxic T Lymphocyte Antigen-4 Down-Regulates T Helper 1 Cells by Increasing Expression of Signal Transducer and Activator of Transcription 3 in Acute.
Presentation transcript:

Modulation of Graft-versus-Host Disease: Role of Regulatory T Lymphocytes  Allan D. Hess  Biology of Blood and Marrow Transplantation  Volume 12, Issue 1, Pages 13-21 (January 2006) DOI: 10.1016/j.bbmt.2005.11.002 Copyright © 2006 American Society for Blood and Marrow Transplantation Terms and Conditions

Figure 1 Schematic illustration of effector mechanism involved in allogeneic and autologous GVHD. Alloreactive T cells transferred along with bone marrow graft recognize and respond to histocompatibility antigen differences in host. Damage to thymic epithelium may induce release of autoreactive T cells that may participate in GVH response. Administration of CsA to autologous BMT recipients inhibits thymic-dependent clonal deletion inducing release of autoreactive T cells that can manifest autoaggression that is identical to allogeneic GVHD. Biology of Blood and Marrow Transplantation 2006 12, 13-21DOI: (10.1016/j.bbmt.2005.11.002) Copyright © 2006 American Society for Blood and Marrow Transplantation Terms and Conditions

Figure 2 Recognition of MHC class II to CLIP complex in autologous GVHD. Autologous effector T cells recognize MHC class II antigens presenting CLIP. In addition to recognition of MHC class II binding domain of CLIP, N-terminal flanking domain appears to interact with Vβ chain of T-cell receptor at or near binding site for staphylococcal enterotoxin B superantigen. Biology of Blood and Marrow Transplantation 2006 12, 13-21DOI: (10.1016/j.bbmt.2005.11.002) Copyright © 2006 American Society for Blood and Marrow Transplantation Terms and Conditions

Figure 3 Development of donor-to-host and self-tolerance. Reconstitution of regulatory compartment allows for down-regulation of alloreactive and autoreactive T cells. CD4+CD25+Foxp3+ T cells activated by APCs may orchestrate establishment of immune tolerance. CD8+CD28- regulatory T cells may also interact to facilitate this state of unresponsiveness. Biology of Blood and Marrow Transplantation 2006 12, 13-21DOI: (10.1016/j.bbmt.2005.11.002) Copyright © 2006 American Society for Blood and Marrow Transplantation Terms and Conditions

Figure 4 Decreased Foxp3 gene expression in patients with GVHD. Peripheral blood lymphocytes were collected and assessed for levels of Foxp3 mRNA transcripts by quantitative polymerase chain reaction [57]. Data were standardized against the glyceraldehyde phosphate dehydrogenase housekeeping gene. Biology of Blood and Marrow Transplantation 2006 12, 13-21DOI: (10.1016/j.bbmt.2005.11.002) Copyright © 2006 American Society for Blood and Marrow Transplantation Terms and Conditions

Figure 5 Correlation of Foxp3 gene expression with grade of acute GVHD. Peripheral blood lymphocytes were collected and assessed for levels of Foxp3 mRNA transcripts by quantitative polymerase chain reaction [57]. Data were standardized against glyceraldehyde phosphate dehydrogenase housekeeping gene. Expression levels of Foxp3 were correlated with grade of acute GVHD and stage of chronic GVHD. Biology of Blood and Marrow Transplantation 2006 12, 13-21DOI: (10.1016/j.bbmt.2005.11.002) Copyright © 2006 American Society for Blood and Marrow Transplantation Terms and Conditions

Figure 6 Temporal analysis of Foxp3 expression in patients developing allogeneic and autologous GVHD. Foxp3 mRNA transcripts were assessed in peripheral blood lymphocytes collected sequentially from patient with allogeneic GVHD (A) or patient with autologous GVHD (B) as previously described [57]. Levels of mRNA transcripts were correlated with disease stage. Biology of Blood and Marrow Transplantation 2006 12, 13-21DOI: (10.1016/j.bbmt.2005.11.002) Copyright © 2006 American Society for Blood and Marrow Transplantation Terms and Conditions

Figure 7 Analysis of CLIP reactive CD4+ T cells after autologous BMT and induction of autologous GVHD. Two-color flow cytometry was used to isolate CD4+ T cells that recognized MHC class II to CLIP complex (A). Peripheral blood lymphocytes were stained with fluoroscein isothiocyanate conjugated CD4 and phycoerythrin conjugated DR2 a tetramer loaded with CLIP. CD4+CLIP reactive T cells were isolated from patient pretransplantation, during active autologous GVHD and upon resolution of autoaggression and assessed for Foxp3 mRNA transcript levels by quantitative polymerase chain reaction. Biology of Blood and Marrow Transplantation 2006 12, 13-21DOI: (10.1016/j.bbmt.2005.11.002) Copyright © 2006 American Society for Blood and Marrow Transplantation Terms and Conditions

Figure 8 In vitro stimulation of regulatory T-cell function. Peripheral blood lymphocytes were stimulated with truncated variants of CLIP presented by autologous APCs as previously described [57]. Variants of CLIP included MHC class II binding domain (BD), BD along with N-terminal flanking domain (N-CLIP), and BD with C-terminal domain (CLIP-C). Levels of Foxp3 mRNA transcripts were assessed 24 hours after stimulation (A). Cells were harvested and assessed for their ability to suppress proliferative response of autologous CD8+ T cells stimulated with autologous APCs that innately express MHC class II to CLIP complex. Proliferation was assessed after 72 hours of culture [57]. Biology of Blood and Marrow Transplantation 2006 12, 13-21DOI: (10.1016/j.bbmt.2005.11.002) Copyright © 2006 American Society for Blood and Marrow Transplantation Terms and Conditions